showed a trendp = 0.013
Interestingly, other microtubule inhibitors (e.g., eribulin, vinorelbine) also showed a trend toward better TNT in ERBB2 -altered breast cancer; vinorelbine, in particular, reached statistical significance (HR = 0.62, 95% CI: 0.43–0.91; p = 0.013) (Table 2 ), although further research is needed [ 32 , 33 ].